Established and Emerging Lipid-Lowering Drugs for Primary and Secondary Cardiovascular Prevention-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Established and Emerging Lipid-Lowering Drugs for Primary and Secondary Cardiovascular Prevention

Published:2023-07-24 Issue:5 Volume:23 Page:477-495
ISSN:1175-3277
Container-title:American Journal of Cardiovascular Drugs
language:en
Short-container-title:Am J Cardiovasc Drugs

Author:

Michaeli Daniel Tobias^ORCID,Michaeli Julia Caroline^ORCID,Albers Sebastian^ORCID,Boch Tobias^ORCID,Michaeli Thomas^ORCID

Funder

Universitätsklinikum Heidelberg

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s40256-023-00594-5.pdf

Reference216 articles.

1. Roth GA, Mensah GA, Johnson CO, et al. Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 Study. J Am Coll Cardiol. 2020;76:2982–3021. https://doi.org/10.1016/j.jacc.2020.11.010.

2. Global Burden of Disease Collaborative Network. Global burden of disease study 2019 (GBD 2019) Reference Life Table. 2021.https://doi.org/10.6069/1D4Y-YQ37 (accessed 24 Sep 2022).

3. Timmis A, Townsend N, Gale CP, et al. European Society of Cardiology: cardiovascular disease statistics 2019. Eur Heart J. 2020;41:12–85. https://doi.org/10.1093/eurheartj/ehz859.

4. Timmis A, Vardas P, Townsend N, et al. European Society of Cardiology: cardiovascular disease statistics 2021. Eur Heart J. 2022;43:716–99. https://doi.org/10.1093/eurheartj/ehab892.

5. Yusuf S, Reddy S, Ôunpuu S, et al. Global burden of cardiovascular diseases. Circulation. 2001;104:2746–53. https://doi.org/10.1161/hc4601.099487.

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the underlying mechanisms of Danshen-Shanzha Decoction on coronary heart disease: An integrated analysis combining pharmacoinformatics and experimental validation;Journal of Ethnopharmacology;2025-01

2. Lipidomic profiling in patients with familial hypercholesterolemia: Abnormalities in glycerolipids and oxysterols;Clinical Biochemistry;2024-10

3. Angiopoietin-like Proteins and Lipoprotein Lipase: The Waltz Partners That Govern Triglyceride-Rich Lipoprotein Metabolism? Impact on Atherogenesis, Dietary Interventions, and Emerging Therapies;Journal of Clinical Medicine;2024-09-04

4. ▼Icosapent ethyl for CV risk reduction;Drug and Therapeutics Bulletin;2024-09

5. Low-density lipoprotein cholesterol stratification reveals differential impact of TyG index on arterial stiffness: a secondary analysis from a Japanese cross-sectional study;2024-08-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3